{
     "PMID": "28137450",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170829",
     "LR": "20170829",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "117",
     "DP": "2017 May 1",
     "TI": "CRF1 receptor-deficiency increases cocaine reward.",
     "PG": "41-48",
     "LID": "S0028-3908(17)30025-4 [pii] 10.1016/j.neuropharm.2017.01.024 [doi]",
     "AB": "Stimulant drugs produce reward but also activate stress-responsive systems. The corticotropin-releasing factor (CRF) and the related hypothalamus-pituitary-adrenal (HPA) axis stress-responsive systems are activated by stimulant drugs. However, their role in stimulant drug-induced reward remains poorly understood. Herein, we report that CRF1 receptor-deficient (CRF1-/-), but not wild-type, mice show conditioned place preference (CPP) responses to a relatively low cocaine dose (5 mg/kg, i.p.). Conversely, wild-type, but not CRF1-/-, mice display CPP responses to a relatively high cocaine dose (20 mg/kg, i.p.), indicating that CRF1 receptor-deficiency alters the rewarding effects of cocaine. Acute pharmacological antagonism of the CRF1 receptor by antalarmin also eliminates cocaine reward. Nevertheless, CRF1-/- mice display higher stereotypy responses to cocaine than wild-type mice. Despite the very low plasma corticosterone concentration, CRF1-/- mice show higher nuclear glucocorticoid receptor (GR) levels in the brain region of the hippocampus than wild-type mice. Full rescue of wild-type-like corticosterone and GR circadian rhythm and level in CRF1-/- mice by exogenous corticosterone does not affect CRF1 receptor-dependent cocaine reward but induces stereotypy responses to cocaine. These results indicate a critical role for the CRF1 receptor in cocaine reward, independently of the closely related HPA axis activity.",
     "CI": [
          "Copyright (c) 2017 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Contarino, Angelo",
          "Kitchener, Pierre",
          "Vallee, Monique",
          "Papaleo, Francesco",
          "Piazza, Pier-Vincenzo"
     ],
     "AU": [
          "Contarino A",
          "Kitchener P",
          "Vallee M",
          "Papaleo F",
          "Piazza PV"
     ],
     "AD": "CNRS, INCIA, UMR 5287, 33000 Bordeaux, France; Univ. Bordeaux, 33000 Bordeaux, France. Electronic address: angelo.contarino@u-bordeaux.fr. INSERM U1215, NeuroCentre Magendie, 33077 Bordeaux, France; Univ. Bordeaux, 33000 Bordeaux, France. INSERM U1215, NeuroCentre Magendie, 33077 Bordeaux, France; Univ. Bordeaux, 33000 Bordeaux, France. Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genova, Italy. INSERM U1215, NeuroCentre Magendie, 33077 Bordeaux, France; Univ. Bordeaux, 33000 Bordeaux, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170127",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (CRF receptor type 1)",
          "0 (Pyrimidines)",
          "0 (Pyrroles)",
          "0 (Receptors, Corticotropin-Releasing Hormone)",
          "0 (Receptors, Glucocorticoid)",
          "0 (antalarmin)",
          "I5Y540LHVR (Cocaine)",
          "W980KJ009P (Corticosterone)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Circadian Rhythm",
          "Cocaine/antagonists & inhibitors/*pharmacology",
          "Conditioning (Psychology)/drug effects",
          "Corticosterone/blood",
          "Dose-Response Relationship, Drug",
          "Hippocampus/metabolism",
          "Male",
          "Mice",
          "Mice, Knockout",
          "Pyrimidines/pharmacology",
          "Pyrroles/pharmacology",
          "Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors/genetics/*physiology",
          "Receptors, Glucocorticoid/metabolism",
          "Reward",
          "Stereotyped Behavior/drug effects"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Cocaine",
          "Corticotropin-releasing factor (CRF) receptor 1",
          "Hypothalamus-pituitary-adrenal (HPA) axis",
          "Reward",
          "Stereotypy"
     ],
     "EDAT": "2017/02/01 06:00",
     "MHDA": "2017/08/30 06:00",
     "CRDT": [
          "2017/02/01 06:00"
     ],
     "PHST": [
          "2016/09/24 00:00 [received]",
          "2017/01/04 00:00 [revised]",
          "2017/01/24 00:00 [accepted]",
          "2017/02/01 06:00 [pubmed]",
          "2017/08/30 06:00 [medline]",
          "2017/02/01 06:00 [entrez]"
     ],
     "AID": [
          "S0028-3908(17)30025-4 [pii]",
          "10.1016/j.neuropharm.2017.01.024 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2017 May 1;117:41-48. doi: 10.1016/j.neuropharm.2017.01.024. Epub 2017 Jan 27.",
     "term": "hippocampus"
}